Northern Trust’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.96M Sell
205,308
-11,139
-5% -$107K ﹤0.01% 2999
2025
Q1
$2.01M Sell
216,447
-6,317
-3% -$58.7K ﹤0.01% 2925
2024
Q4
$3.1M Buy
222,764
+8,411
+4% +$117K ﹤0.01% 2784
2024
Q3
$5.04M Buy
214,353
+58,902
+38% +$1.38M ﹤0.01% 2468
2024
Q2
$2.49M Sell
155,451
-1,021
-0.7% -$16.3K ﹤0.01% 2783
2024
Q1
$2.57M Buy
156,472
+4,222
+3% +$69.2K ﹤0.01% 2834
2023
Q4
$2.11M Buy
152,250
+10,651
+8% +$148K ﹤0.01% 2985
2023
Q3
$1.95M Buy
141,599
+1,431
+1% +$19.7K ﹤0.01% 2957
2023
Q2
$2.39M Buy
140,168
+32,626
+30% +$556K ﹤0.01% 2916
2023
Q1
$1.73M Buy
107,542
+1,775
+2% +$28.5K ﹤0.01% 3001
2022
Q4
$804K Buy
105,767
+1,959
+2% +$14.9K ﹤0.01% 3341
2022
Q3
$912K Buy
103,808
+674
+0.7% +$5.92K ﹤0.01% 3331
2022
Q2
$738K Buy
103,134
+3,030
+3% +$21.7K ﹤0.01% 3418
2022
Q1
$1.07M Sell
100,104
-3,389
-3% -$36.3K ﹤0.01% 3389
2021
Q4
$1.46M Buy
+103,493
New +$1.46M ﹤0.01% 3388